Key terms

About VRCA

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VRCA news

Mar 01 7:28am ET RBC Capital Remains a Buy on Verrica Pharmaceuticals (VRCA) by TipRanks Mar 01 7:06am ET Buy Rating Affirmed for Verrica Pharmaceuticals Following Strong Ycanth Launch and Strategic Market Expansion by TipRanks Mar 01 6:28am ET Verrica Pharmaceuticals Outperforms with YCANTH Sales, Promising Outlook Spurs Buy Rating by TipRanks Mar 01 6:22am ET Verrica Pharmaceuticals price target raised to $13 from $12 at H.C. Wainwright by TipRanks Feb 29 11:45am ET Buy Rating Affirmed for Verrica Pharmaceuticals Amidst Promising Ycanth Launch and Market Acceptance by TipRanks Feb 29 7:34am ET Verrica Pharmaceuticals reports Q4 EPS (53c), consensus (53c) by TipRanks Feb 12 3:06pm ET Verrica Pharmaceuticals (NASDAQ:VRCA) Is Egging on Contrarian Options Traders by TipRanks Feb 05 7:34am ET Verrica Pharmaceuticals files lawsuit against Dormer Laboratories by TipRanks Jan 05 7:30am ET Verrica Pharmaceuticals announces last patient dosed in Phase 2 trial of VP-315 by TipRanks Jan 04 7:32am ET Verrica Pharmaceuticals receives Type C meeting minutes on YCANTH development by TipRanks Jan 03 7:32am ET Verrica Pharmaceuticals announces specialty pharmacy agreement with Walgreens by TipRanks Dec 21 6:23am ET Insider Trading: Verrica Stock (NASDAQ:VRCA) Gained on $6.9M Insider Buy by TipRanks Dec 15 6:02am ET Torii Pharmaceutical reports ‘positive’ results from Phase 3 trial of TO-208 by TipRanks

No recent press releases are available for VRCA

VRCA Financials

1-year income & revenue

Key terms

VRCA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VRCA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days